Skip to main content

Table 3 Comparison of the laboratory results of patients with EGC between the delayed bleeding group and the nonbleeding group

From: External validation of the BEST-J score and a new risk prediction model for ESD delayed bleeding in patients with early gastric cancer

 

Nonbleeding group (n = 417)

Delayed bleeding group (n = 27)

P value

Hemoglobin value [n (%)]

 

0.061

 ≥ 90 g/L

417 (100.0)

26 (96.3)

 

 < 90 g/L

0 (0.0)

1 (3.7)

 

Platelet value [n (%)]

 

1.000

 ≥ 125 × 109/L

389 (93.3)

26 (96.3)

 

 < 125 × 109/L

28 (6.7)

1 (3.7)

 

PT [n (%)]

  

0.397

 ≤ 13.5 s

410 (98.3)

26 (96.3)

 

 > 13.5 s

7 (1.7)

1 (3.7)

 

PT(A) [n (%)]

  

0.650

 ≥ 80%

395 (94.7)

25 (92.6)

 

 < 80%

22 (5.3)

2 (7.4)

 

INR [n (%)]

  

0.315

 ≤ 1.2

412 (98.8)

26 (96.3)

 

 > 1.2

5 (1.2)

1 (3.7)

 

Prolongation of APTT [n (%)]

 

0.009*

 No

406 (97.4)

23 (85.2)

 

 Yes

11 (2.6)

4 (14.8)

 
  1. APTT, activated partial thromboplastin time; EGC, early gastric cancer; INR, international standardized ratio; PT, prothrombin time; PT(A), prothrombin time activity
  2. *P < 0.05
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us